RecruitingPhase 4NCT07828210

NeuroAiD Patient-Reported Outcomes in Patients With Mild to Moderate Ischemic Stroke

A Randomized, Controlled Study Evaluating the Efficacy and Safety of MLC901 (NeuroAiD™ II) in Patients With Mild to Moderate Ischemic Stroke.

Sponsor

EVD Pharmacy and Medical Company Limited

Enrollment

80 participants

Start Date

Sep 10, 2026

Study Type

INTERVENTIONAL

Conditions

Stroke, Ischemic Stroke Stroke, Acute Ischemic Stroke, Cardiovascular Stroke, Cryptogenic

Summary

This is a randomized, controlled, open-label study of MLC901 (NeuroAiD™ II) in patients with mild to moderate ischemic stroke. Eligible participants will be randomized in a 1:1 ratio to receive MLC901 in combination with standard treatment or standard treatment alone for 12 weeks.

Eligibility

Min Age: 18 YearsMax Age: 80 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a drug called MLC901 and Standard treatment for acute ischemic stroke for people with stroke, stroke, acute ischemic, and other related conditions. The study is currently recruiting participants at 1 location. People eligible for this study include aged 18 Years to 80 Years.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DRUGMLC901

MLC901 (NeuroAiD™ II) 400 mg hard capsules, administered orally at a dose of 2 capsules three times daily for 12 weeks, in combination with standard treatment according to the protocol.

OTHERStandard treatment for acute ischemic stroke

Participants will receive standard treatment for acute ischemic stroke according to the study protocol for 12 weeks

Locations(1)

Traditional Medicine Institute

Ho Chi Minh City, Vietnam

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07828210

Related Trials

Screening for Social Determinants of Health (SDOH) and Cognitive Function in Individuals With History of Stroke

NCT066159731 location

Long-term Brain Stimulation of the Motor Ventral Thalamus (VOP/VIM) to Improve Motor Function

NCT070563481 location

Transcranial Direct Current Stimulation and Cognitive Behavioural Programme on Post-stroke Fatigue

NCT068108171 location

Stimulating Specific Brain Areas (VOP/VIM) With Electricity to Improve Movement and Muscle Control

NCT070563611 location

Head of Bed After Ischemic Stroke Thrombectomy (HoBIT)

NCT07367633